These most recent patents include:
- US Patent 8383594 was accorded to the invention titled “Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals”. Research supports the company’s Olepent ingredient’s stability and capability to deliver the active principles right into the target areas of the skin with beneficial effects on aspect of skin aging.
- “Inotilone derivatives as coherent biological response modifier (cBMR)” (US Patent 8394852) discloses a new composition of matter, an inotilone analog, and also its ability to modulate biological responses.
- US Patent 8853407, a process patent for the synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal. The invention is for a shorter, practical, scalable synthetic method for the synthesis of the 4-aryl 1, 4-diacyl dihydropyridine group of compounds, which overcomes all the technical challenges of earlier synthetic routs.
- Another patent for Olepent (US Patent 8987212) claims therapeutic efficacy in effectively reducing skin wrinkling through anti-elastase activity. The signal peptide technology disclosed in this patent demonstrates an effective therapeutic means to counter the ill effects of serine protease enzymes on the human skin.